THE SIGNIFICANCE OF SPECIFIC PNEUMOCOCCUS TYPES IN DISEASE, INCLUDING TYPES IV TO XXXII (COOPER)
Authors: Maxwell Finland
Journal: Annals of Internal Medicine (1937)

Article1 April 1937THE SIGNIFICANCE OF SPECIFIC PNEUMOCOCCUS TYPES IN DISEASE, INCLUDING TYPES IV TO XXXII (COOPER)MAXWELL FINLAND, M.D.MAXWELL FINLAND, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-10-10-1531 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe recent increase in the use of specific serum for the treatment of pneumonia has been accompanied by a growing interest in the newer types of pneumococci1in many parts of this and other countries. It seems appropriate, therefore, to present a brief résumé of 3682 cases admitted to the Boston City Hospital, from which pneumococci were cultured and typed with the aid of serums for these new types. Approximately one-third of these cases, previously reported,2occurred before June 1, 1932 and were typed with serums for Types I to XX. The remaining cases were admitted before July 1, 1936...Bibliography1. COOPEREDWARDSROSENSTEIN GMC(a) : The separation of types among the pneumococci hitherto called group IV and the development of therapeutic antiserums for these types, Jr. Exper. Med., 1929, xlix, 461. (b) COOPER, G., ROSENSTEIN, C., WALTER, A., and PEIZER, L.: The further separation of types among the pneumococci hitherto included in Group IV and the development of antisera for these types, Ibid., 1932, lv, 531. CrossrefGoogle Scholar2. SUTLIFFFINLAND WDM: The significance of the newly classified types of pneumococci in disease: Types IV to XX inclusive, Jr. Am. Med. Assoc., 1933, ci, 1289. CrossrefGoogle Scholar3. SUTLIFFFINLAND WDM(a) : Type I pneumococcic infections with especial reference to specific serum treatment, New Eng. Jr. Med., 1934, ccx, 237. (b) FINLAND, M., and SUTLIFF, W. D.: Infections with pneumococcus Type III and Type VIII: Characterization of pneumonia caused by pneumococcus Type III and that associated with a biologically closely related organism, pneumococcus Type VIII, Arch. Int. Med., 1934, liii, 491.(c) FINLAND, M., and DOWLING, H. F.: Pneumococcus Type II and Type V infections, Ibid., 1936, lviii, 598. (d) FINLAND, M., RUEGSEGGER, J. M., DOWLING, H. F., and TILGHMAN, R. C.: Infections with pneumococcus Type VII, Am. Jr. Med. Sci., 1937, cxciii, 48. CrossrefGoogle Scholar4. COLE RI: Acute pulmonary infections, De Lamar Lectures, 1927-1928, Williams and Wilkins Company, Baltimore. Google Scholar5. BULLOWAWILCOX JGC(a) : Incidence of bacteremia in the pneumonias and its relation to mortality, Arch. Int. Med., 1935, lv, 558. (b) TILGHMAN, R. C., and FINLAND, M.: An analysis of the clinical significance of bacteremia in pneumococcus pneumonia, Ibid. (In press.) CrossrefGoogle Scholar6. FINLAND M(a) : Adequate dosage in the specific serum treatment of pneumococcus Type I pneumonia, Am. Jr. Med. Sci., 1936, cxcii, 849. (b) FINLAND, M., and SUTLIFF, W. D.: The specific serum treatment of pneumococcus Type II pneumonia, Jr. Am. Med. Assoc., 1933, c, 560. (c) FINLAND, M., and DOWLING, H. F.: The dose of antibody effective in the treatment of pneumococcus Type II pneumonia, Am. Jr. Med. Sci., 1936, cxci, 658. (d) FINLAND, M., and TILGHMAN, R. C.: Clinical and immunologic observations in cases of pneumococcus Type V pneumonia treated with specific antibody, New England Jr. Med., 1936, ccxv, 1211. (e) FINLAND, M., TILGHMAN, R. C., RUEGSEGGER, J. M., and DOWLING, H. F.: Clinical and immunologic observations in cases of pneumococcus Type VII pneumonia treated with concentrated type-specific antibody, Am. Jr. Med. Sci., 1937, cxciii, 59. Google Scholar7. FINLAND M: The significance of mixed infections in pneumococcic pneumonia, Jr. Am. Med. Assoc., 1934, ciii, 1681. CrossrefGoogle Scholar8. GUNDELSEITZ ML: Die Pneumokokkentypen in der gesunden Bevölkerung, Klin. Wchnschr., 1933, xii, 929. CrossrefGoogle Scholar9. BULLOWA JG(a) : Voraussetzungen und Technik der Pneumoniebehandlung, Klin. Wchnschr., 1936, xv, 769. (b) NEMIR, R. L., ANDREWS, E. T., and VINOGRAD, J.: Pneumonia in infants and in children; a bacteriologic study with special reference to clinical significance, Am. Jr. Dis. Child., 1936, li, 1277. (c) RAIA, A., PLUMMER, N., and SHULTZ, S.: New types of pneumococci in the pneumonias of children, Am. Jr. Dis. Child., 1931, xlii, 57. CrossrefGoogle Scholar10. BULLOWA JG(a) : Therapeutic value of specific Type VII (Cooper) antipneumococcic serum, Libman Anniv. Vols., 1932, i, 283. (b) Therapeutic pneumococcus Type VIII (Cooper) serum, Jr. Am. Med. Assoc., 1934, cii, 1560. (c) Pneumonia due to pneumococcus Type XIV (Cooper) and its treatment with specific antiserum, Jr. Clin. Invest., 1935, xiv, 373. (d) BULLOWA, J. G. M., and WILCOX, C.: Therapeutic serum for pneumococcus Type V (Cooper) pneumonia, Jr. Clin. Invest., 1936, xv, 711. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Boston, Massachusetts*Received for publication January 26, 1937.From the Thorndike Memorial Laboratory, Second and Fourth Medical Services (Harvard), Boston City Hospital, and the Department of Medicine, Harvard Medical School, Boston, Mass.This study was aided, in part, by a grant given in memory of Francis Weld Peabody by the Ella Sachs Plotz Foundation.†In the tables, the Types XXVI and XXX have been omitted. The former is probably identical with Type VI and the latter is either closely related to or identical with Type XV. Type XXX was identified in two cases, one with lobar pneumonia, the other with a common cold; these are included with the Type XV cases. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byGlucocorticoid-Augmented Efferocytosis Inhibits Pulmonary Pneumococcal Clearance in Mice by Reducing Alveolar Macrophage Bactericidal FunctionCLINICAL EVALUATION OF CARDIAC INVOLVEMENT IN PNEUMONIAImpact of the Pneumococcal Conjugate Vaccine on Pneumococcal Parapneumonic EmpyemaPneumococcal pericarditis: A persisting problem in contemporary diagnosisChanges in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974The classic bacterial pneumoniasDie PneumonienEmpyema Thoracis: An Analytical Study of 500 Cases with General Remarks 1 April 1937Volume 10, Issue 10Page: 1531-1543KeywordsCommon coldHospital medicineMedical servicesMemoryPneumococcusPneumoniaResearch laboratories ePublished: 1 December 2008 Issue Published: 1 April 1937 PDF downloadLoading ...